Literature DB >> 18563635

Newborn screening for methylmalonic acidurias--optimization by statistical parameter combination.

M Lindner1, S Ho, S Kölker, G Abdoh, G F Hoffmann, P Burgard.   

Abstract

With the introduction of tandem mass spectrometry, newborn screening for disorders of propionate metabolism became widely available. However, there is controversy whether population screening for these disorders should be performed. The most widely used primary metabolite C(3) itself has a poor specificity or lacks 100% sensitivity for milder forms and/or defects of cobalamin metabolism. Strategies to improve specificity have included the calculation of metabolite ratios (e.g. C(3)/C(2)) or second-tier strategies with analysis of methylmalonic acid or 2-methylcitric acid from the primary screening specimen. We report the results of a new statistical approach to identify parameter combinations that allow for 100% sensitivity as well as increased specificity. The promising results of this alternative approach will have to be substantiated on larger data sets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563635     DOI: 10.1007/s10545-008-0892-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.750


  15 in total

1.  Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.

Authors:  D H Chace; J C DiPerna; T A Kalas; R W Johnson; E W Naylor
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

2.  Arguments for early screening: a clinician's perspective.

Authors:  John H Walter
Journal:  Eur J Pediatr       Date:  2003-11-29       Impact factor: 3.183

Review 3.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.

Authors:  Donald H Chace; Theodore A Kalas; Edwin W Naylor
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

4.  Newborn screening: toward a uniform screening panel and system--executive summary.

Authors: 
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

5.  Acylcarnitine profiles of preterm infants over the first four weeks of life.

Authors:  Jochen Meyburg; Andreas Schulze; Dirk Kohlmueller; Johannes Pöschl; Otwin Linderkamp; Georg F Hoffmann; Ertan Mayatepek
Journal:  Pediatr Res       Date:  2002-11       Impact factor: 3.756

Review 6.  A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening.

Authors:  J Hewlett; S E Waisbren
Journal:  J Inherit Metab Dis       Date:  2006-08-17       Impact factor: 4.982

Review 7.  'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry.

Authors:  Carlo Dionisi-Vici; Federica Deodato; Wulf Röschinger; William Rhead; Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

8.  Age-related variations in acylcarnitine and free carnitine concentrations measured by tandem mass spectrometry.

Authors:  Catia Testa Cavedon; Pierre Bourdoux; Karl Mertens; Hong Vien Van Thi; Nadine Herremans; Corinne de Laet; Philippe Goyens
Journal:  Clin Chem       Date:  2005-02-11       Impact factor: 8.327

9.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

Authors:  Andreas Schulze; Martin Lindner; Dirk Kohlmüller; Katharina Olgemöller; Ertan Mayatepek; Georg F Hoffmann
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

10.  Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007).

Authors:  D Matern; S Tortorelli; D Oglesbee; D Gavrilov; P Rinaldo
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

View more
  17 in total

1.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

Review 2.  Newborn blood spot screening: new opportunities, old problems.

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2009-05-04       Impact factor: 4.982

3.  Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.

Authors:  Yosuke Shigematsu; Ikue Hata; Go Tajima
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

Review 4.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

5.  Treatable cause of hereditary spastic paraplegia: eight cases of combined homocysteinaemia with methylmalonic aciduria.

Authors:  Yanping Wei; Yan Zhou; Jing Yuan; Jun Ni; Min Qian; Liying Cui; Bin Peng
Journal:  J Neurol       Date:  2019-06-15       Impact factor: 4.849

6.  Expansion of the Phenotypic Spectrum of Propionic Acidemia with Isolated Elevated Propionylcarnitine.

Authors:  Gerarda Cappuccio; Paldeep S Atwal; Taraka R Donti; Kiki Ugarte; Nadia Merchant; William J Craigen; V Reid Sutton; Sarah H Elsea
Journal:  JIMD Rep       Date:  2016-11-30

7.  Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.

Authors:  James D Weisfeld-Adams; Mark A Morrissey; Brian M Kirmse; Bobbie R Salveson; Melissa P Wasserstein; Peter J McGuire; Sherlykutty Sunny; Jessica L Cohen-Pfeffer; Chunli Yu; Michele Caggana; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-09-27       Impact factor: 4.797

8.  Analysis of methylcitrate in dried blood spots by liquid chromatography-tandem mass spectrometry.

Authors:  Osama Y Al-Dirbashi; Nathan McIntosh; Christine McRoberts; Larry Fisher; Mohamed S Rashed; Nawal Makhseed; Michael T Geraghty; Tomofumi Santa; Pranesh Chakraborty
Journal:  JIMD Rep       Date:  2014-07-06

9.  Newborn Screening Programmes in Europe, Arguments and Efforts Regarding Harmonisation: Focus on Organic Acidurias.

Authors:  Friederike Hörster; Stefan Kölker; J Gerard Loeber; Martina C Cornel; Georg F Hoffmann; Peter Burgard
Journal:  JIMD Rep       Date:  2016-06-26

10.  Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.

Authors:  Sabrina Malvagia; Christopher A Haynes; Laura Grisotto; Daniela Ombrone; Silvia Funghini; Elisa Moretti; Kathleen S McGreevy; Annibale Biggeri; Renzo Guerrini; Raquel Yahyaoui; Uttam Garg; Mary Seeterlin; Donald Chace; Victor R De Jesus; Giancarlo la Marca
Journal:  Clin Chim Acta       Date:  2015-09-11       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.